Authors
Alvares M.A., Shishkin M.M., Fayzrakhmanov R.R., Saraeva S.N.
Pirogov National Medical and Surgical Center, Moscow
Abstract
Objective. To study the long‑term outcomes of surgical treatment for advanced proliferative diabetic retinopathy (PDR) in young patients with type 1 diabetes mellitus.
Materials and Methods. Retrospective analysis of treatment outcomes for 38 patients (38 eyes) with advanced PDR. The mean age of the patients was 28.9 ± 4.4 years. All patients underwent sparing 25G vitrectomy with episcleral circular buckling performed when indicated.
Results. In all cases, we encountered technical difficulties during primary vitrectomy when separating the posterior hyaloid membrane from the retina. In eyes with extensive fibrovascular proliferation, complete removal of the fibrotic tissue was deliberately avoided. In such cases, episcleral buckling was used to relieve circumferential traction along the posterior margin of the vitreous base and facilitate the removal of the peripheral vitreous. Vision was preserved and improved in 68.4% of patients (26 eyes). The best functional outcomes were observed in young patients who had high baseline visual acuity and achieved their target HbA1c levels.
Conclusion. The surgical management strategy for young patients with advanced PDR should be personalized, incorporating a thorough preoperative assessment and collaboration with an endocrinologist. Refraining the complete removal of fibrous tissue at sites of pathological adhesion allows for better anatomical and functional outcomes. Long-term follow-up data indicate that residual areas of fibrosis adherent to the retina do not serve as foci for reproliferation following the relief of traction.
Keywords: advanced proliferative diabetic retinopathy, young patients, sparing vitreoretinal surgery, episcleral circular buckling, type 1 diabetes mellitus.
References
1. Ogle GD, Wang F, Haynes A, et al. Global type 1 diabetes prevalence, incidence, and mortality estimates 2025: Results from the International Diabetes Federation Atlas, 11th Edition, and the T1D Index Version 3.0. Diabetes Research and Clinical Practice. 2025; 225: 112277. doi: 10.1016/j.diabres.2025.112277.
2. Liao M, Wang X, Yu J, et al. Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients. BMC Ophthalmology. 2020; 20(1): 416. doi: 10.1186/s12886-020-01688-3.
3. Kumar K, Baliga G, Babu N, et al. Clinical features and surgical outcomes of complications of proliferative diabetic retinopathy in young adults with type 1 diabetes mellitus versus type 2 diabetes mellitus — A comparative observational study. Indian Journal of Ophthalmology. 2021; 69(11): 3289-3295. doi: 10.4103/ijo.IJO_1293_21.
4. Lebedev YB, Khudyakov AY, Sorokin EL. Features of surgery for proliferative diabetic retinopathy in young patients. Sovremennye tekhnologii v oftal’mologii. 2021; 1:113-116. (In Russ.)
5. Babayeva DB, Shishkin MM, Fayzrakhmanov RR, Konovalova KI. Vitreopapillary traction syndrome in patients with proliferative diabetic retinopathy. Russian Annals of Ophthalmology. 2021; 137(6): 38 44. (In Russ.)
6. Arevalo JF, Maia M, Flynn HWJr, et al. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. British Journal of Ophthalmology. 2008; 92(2): 213-216. doi: 10.1136/bjo.2007.127142.
7. Kuiper EJ, Van Nieuwenhoven FA, de Smet MD, et al. The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy. PLoS ONE. 2008; 3(7): e2675. doi: 10.1371/journal.pone.0002675.
8. Abouelkheir HY, Badawi AE. Abdelkader AM, et al. Does the scleral encircling band provide a protective effect against the progression of diabetic retinopathy? International Journal of Ophthalmology. 2019; 12(9): 1408-1414. doi: 10.18240/ijo.2019.09.06.
9. Golovin AS. Scleral buckling for recurrent retinal detachment after previous endovitreal surgery in patients with advanced proliferative diabetic retinopathy. Oftal’mologiya. 2025; 22(1): 35-40. (In Russ.) doi: 10.18008/1816-5095-2025-1-35-40.
10. Early Treatment Diabetic Retinopathy Study Research Group et al. Early photocoagulation for diabetic retinopathy: ETDRS report number 9. Ophthalmology. 1991; 98(5): 766-785.
11. Roy R, Das MK, Pal BP, et al. The effects of renal transplantation on diabetic retinopathy: Clinical course and visual outcomes. Indian Journal of Ophthalmology. 2013; 61(10): 552-556. doi: 10.4103/0301-4738.121067.
12. Shishkin MM, Boyko EV, et al. A tissue-sparing approach to vitreoretinal surgery for proliferative diabetic retinopathy. In: Sovremennye tekhnologii lecheniya vitreoretinal’noy patologii: proceedings of a scientific and practical conference. Moscow; 2002: 409-412. (In Russ.)
13. Chen SN, Chen SJ, Wu TT, et al. Refining vitrectomy for proliferative diabetic retinopathy. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2023; 261(12): 3659-3670. doi: 10.1007/s00417-023-06134-w.
14. Konovalova KI, Shishkin MM, Fayzrakhmanov RR. Phacoemulsification of primary cataract by the second stage after vitreoretinal surgery of proliferative diabetic retinopathy patients. Diabetes mellitus. 2020; 23(5): 452-458. (In Russ.)
15. Shishkin MM, Safarli NN, et al. Tissue-sparing vitreoretinal surgery for advanced proliferative diabetic retinopathy: rationale, technique, and long-term outcomes. Vestnik Natsional’nogo mediko-khirurgicheskogo Tsentra im. N.I. Pirogova. 2009; 4(2): 23-28. (In Russ.)


